CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research focuses on improving clinical trials for rare diseases, particularly in small patient groups. It aims to develop innovative statistical methodologies that enhance trial design and analysis, ensuring more reliable and cost-effective results for therapies targeting these conditions.
There exist more than 7000 rare diseases worldwide and the European Society of Paediatric Oncology stated that 75% of rare diseases affect children and 30% of rare disease patients die before the age of five.
Usual statistical methods for proving efficacy and safety of therapies fail to provide cost-efficient and reliable results in small populations.
There is a pressing need to integrate a broad range of innovative methodologies improving clinical trials in the setting of small sample populatio…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Aachen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Bochum
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
MEDIZINISCHE UNIVERSITAET WIEN
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
